Search is restricted to the following diseases:
Search Results for "Alamandine" - 57 interactions found in 12 entries.
|
|
|
Interactor1 (Subject) |
|
Interaction type |
Interactor2 (Object) |
additional information |
|
|
|
|
9,686
|
| 102208 |
Alamandine
|
|
increases_quantity of
|
NO
|
in ventricular cardiomyocytes
|
| 102330 |
Alamandine
|
|
increases_activity of
|
AMPK
|
in ventricular cardiomyocytes
|
| 102332 |
Alamandine
|
NOT |
affects_phosphorylation of
|
AKT1
|
at Ser473
|
| 102334 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
|
| 102335 |
Alamandine
|
|
decreases_activity of
|
cardiac hypertrophy
|
|
| 102336 |
Alamandine
|
|
affects_expression of
|
MYH7
|
|
| 102337 |
Alamandine
|
|
affects_activity of
|
Voltage-gated calcium channel, L-type
|
|
|
29443552
|
Cardiovascular disease
|
|
9,687
|
| 102209 |
Angiotensin A
|
|
increases_quantity of
|
Alamandine
|
|
| 102338 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 102340 |
Nephropathy
|
|
increases_quantity of
|
Alamandine
|
in blood plasma
|
| 102341 |
Alamandine
|
|
interacts (colocalizes) with
|
MRGPRD
|
|
|
23446738
|
Cardiovascular disease
|
|
9,698
|
| 102342 |
Alamandine
|
|
decreases_activity of
|
hypertension
|
|
| 102343 |
Alamandine
|
|
decreases_quantity of
|
Collagen I
|
|
| 102344 |
Alamandine
|
|
decreases_quantity of
|
Collagen III
|
|
| 102345 |
Alamandine
|
|
decreases_quantity of
|
Fibronectin
|
|
| 102346 |
Angiotensin (1-7)
|
|
increases_quantity of
|
Alamandine
|
|
|
23446738
|
Cardiovascular disease
|
|
11,922
|
| 117268 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
in LPS plus IFNG-stimulated macrophages
|
| 117269 |
Alamandine
|
|
decreases_expression of
|
TNF
|
in LPS plus IFNG-stimulated macrophages; via MRGPRD
|
| 117271 |
Alamandine
|
|
decreases_expression of
|
CCL2
|
in LPS plus IFNG-stimulated macrophages; via MRGPRD
|
| 117273 |
Alamandine
|
|
decreases_expression of
|
IL1B
|
in LPS plus IFNG-stimulated macrophages; via MRGPRD
|
| 117284 |
Alamandine
|
|
decreases_activity of
|
inflammatory response
|
in LPS plus IFNG-stimulated macrophages; via MRGPRD
|
|
30918468
|
Lung disease
|
|
12,029
|
| 118025 |
Alamandine
|
|
increases_activity of
|
MAS1
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
12,035
|
| 118115 |
Angiotensin A
|
|
increases_quantity of
|
Alamandine
|
|
| 118117 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 118118 |
Alamandine
|
|
increases_activity of
|
vasodilation
|
|
| 118119 |
Alamandine
|
|
decreases_activity of
|
fibrosis
|
|
| 118120 |
Alamandine
|
|
decreases_activity of
|
hypertension
|
|
| 118121 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
12,059
|
| 118254 |
Alamandine
|
|
increases_activity of
|
vasodilation
|
in aortic ring; via MRGPRD
|
|
23446738
|
Cardiovascular disease
|
|
14,067
|
| 132942 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 132943 |
Alamandine
|
|
increases_activity of
|
vasodilation
|
|
| 132944 |
Alamandine
|
|
decreases_activity of
|
inflammatory response
|
|
|
33169633
|
COVID-19
|
|
14,144
|
| 133623 |
Alamandine
|
|
decreases_activity of
|
ischemia-reperfusion injury
|
|
| 133701 |
Alamandine
|
|
decreases_activity of
|
apoptotic process
|
after ischemia-reperfusion injury
|
| 133702 |
Alamandine
|
|
decreases_quantity of
|
TNF
|
after ischemia-reperfusion injury
|
| 133703 |
Alamandine
|
|
decreases_quantity of
|
IL1B
|
after ischemia-reperfusion injury
|
| 133704 |
Alamandine
|
|
decreases_quantity of
|
IL6
|
after ischemia-reperfusion injury
|
| 133705 |
Alamandine
|
|
increases_phosphorylation of
|
MAPK14
|
after ischemia-reperfusion injury
|
| 133706 |
Alamandine
|
|
increases_phosphorylation of
|
ERK
|
after ischemia-reperfusion injury
|
| 133707 |
Alamandine
|
|
increases_phosphorylation of
|
JUN
|
after ischemia-reperfusion injury
|
| 133708 |
Alamandine
|
|
decreases_activity of
|
I-kappaB kinase/NF-kappaB signaling
|
after ischemia-reperfusion injury
|
|
31378915
|
Cardiovascular disease
|
|
14,231
|
| 134357 |
Angiotensin (1-7)
|
|
increases_quantity of
|
Alamandine
|
via decarboxylation of Asp1
|
| 134360 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 134363 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
|
| 134389 |
Alamandine
|
|
decreases_activity of
|
vasoconstriction
|
via MRGPRD
|
| 134390 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
|
|
30978131
|
Cardiovascular disease
|
|
14,282
|
| 134742 |
Alamandine
|
|
decreases_activity of
|
Retinopathy, diabetic
|
|
|
29761600
|
Retinopathy, diabetic
|
|
14,352
|
| 135313 |
Alamandine
|
|
decreases_activity of
|
ischemia-reperfusion injury
|
in heart; via MRGPRD
|
| 135314 |
Alamandine
|
|
increases_quantity of
|
Atrial natriuretic peptide
|
in heart; via MRGPRD
|
| 135315 |
Alamandine
|
|
decreases_expression of
|
BAX
|
|
| 135316 |
Alamandine
|
|
decreases_expression of
|
CASP3
|
|
| 135317 |
Alamandine
|
|
decreases_expression of
|
CASP9
|
|
| 135318 |
Alamandine
|
|
increases_expression of
|
BCL2
|
|
| 135319 |
Alamandine
|
|
increases_expression of
|
SOD2
|
|
| 135320 |
Alamandine
|
|
increases_expression of
|
CAT
|
|
| 135321 |
Alamandine
|
|
increases_expression of
|
HMOX1
|
|
| 135322 |
Alamandine
|
|
increases_activity of
|
MRGPRD
|
in heart
|
|
29998915
|
Cardiovascular disease
|
CIDeRplus